2021
DOI: 10.1037/ser0000463
|View full text |Cite
|
Sign up to set email alerts
|

Racial and ethnic disparities in clinical outcomes six months after receiving a PTSD diagnosis in Veterans Health Administration.

Abstract: Because the mental health burden of PTSD among many racial and ethnic minority veterans is greater than among non-Latinx Whites (NLW) and there are disparities in VHA mental health treatment, we evaluated variations in clinical outcomes across veteran racial and ethnic groups in a large national cohort diagnosed with PTSD in VHA. This was a planned secondary analysis of patient-reported outcomes from a large prospective cohort study of veterans with PTSD. Veterans were surveyed immediately following a PTSD dia… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
8
0

Year Published

2022
2022
2023
2023

Publication Types

Select...
7
1

Relationship

1
7

Authors

Journals

citations
Cited by 14 publications
(8 citation statements)
references
References 62 publications
0
8
0
Order By: Relevance
“…Although participants included in the United States studies appear somewhat representative of the population of United States veterans overall, they do not appear to be fully representative of the population of treatment-seeking veterans with PTSD more broadly, and PTSD is known to affect Black and Hispanic veterans at elevated rates [ 81 ]. White veterans are greatly overrepresented in the overall sample (78%, compared to 46% of treatment-seeking veterans with PTSD in the United States) while Black veterans in particular appear highly underrepresented (7%, compared to 20%) [ 82 ]. These could be indicators that research studies are recruiting veterans from different demographic characteristics disproportionately or may be a sign that the complementary intervention of a psychiatric assistance dog is not equally accessible to all veterans irrespective of demographic characteristics.…”
Section: Discussionmentioning
confidence: 99%
“…Although participants included in the United States studies appear somewhat representative of the population of United States veterans overall, they do not appear to be fully representative of the population of treatment-seeking veterans with PTSD more broadly, and PTSD is known to affect Black and Hispanic veterans at elevated rates [ 81 ]. White veterans are greatly overrepresented in the overall sample (78%, compared to 46% of treatment-seeking veterans with PTSD in the United States) while Black veterans in particular appear highly underrepresented (7%, compared to 20%) [ 82 ]. These could be indicators that research studies are recruiting veterans from different demographic characteristics disproportionately or may be a sign that the complementary intervention of a psychiatric assistance dog is not equally accessible to all veterans irrespective of demographic characteristics.…”
Section: Discussionmentioning
confidence: 99%
“…Research has documented a reduced propensity to seek mental health treatment (Mojaverian & Kim, 2013), a lower likelihood of receiving quality health treatment, and poorer treatment outcomes for people from culturally diverse communities (Hwang, 2006). Further treatment outcome disparities have been reported across racial/ethnic cultural groups with Latinx and African American veterans less likely than European Americans to report reductions in PTSD symptoms (Spoont et al, 2020). Thus, it is critical for research to identify cultural factors that may impact on treatment retention and outcomes and provide clinicians with guidance on culturally tailoring evidence-based treatments (Hwang, 2006).…”
Section: Discussionmentioning
confidence: 99%
“…However, the data used in this investigation were from a clinical sample of patients admitted to a Level I trauma center, where mental health screening and follow-up is rare (Love & Zatzick, 2014), and screening tools such as the PCL-5 are cost-effective and low-burden approaches to follow-up. Second, only one measure of PTSD was used in this study, whereas there are numerous measures available for use in clinical settings (see Spoont et al, 2013 for a review), limiting the generalizability of results. Despite this, the PCL-5 is a valid and widely-used measure of PTSD (Belvins et al, 2015; Weathers et al, 2013), thus, its use in this study also is a strength.…”
Section: Discussionmentioning
confidence: 99%